SAMP reported a healthy 12% YoY increase in earnings for 3QCY17, with net interest income and net fee & commission income up by 25% YoY and 23% YoY respectively amid a controlled increase in operating expenses (cost to income ratio -5.9ppt YoY to 43%). The bank’s NIM improved marginally YoY and QoQ (+10bps and +4bps respectively) amid upward re-pricing of new advances, while at Group level the CASA ratio recorded an anticipated decline (-6.1ppt YoY; -4.7ppt YTD) to 34% on the back of a sharp increase in SAMP’s fixed deposit base. NPLs remained higher YTD for the bank but improved QoQ (from 1.61% in 4QCY16 and 1.77% in 2QCY17 to 1.74% in 3QCY17), and remain one of the lowest among the larger private sector banks. Loan book growth for SAMP has remained strong (+18% in 9MCY17; +4.9% QoQ), despite an industry wide slowdown in the pace of credit growth, while on the funding side, term deposits have increased by 30% in 9MCY17 vs. a 19% increase in SAMP’s total deposit base, with SAMP having offered a rate of 12% on its one year FDs during the quarter, +1ppt higher than peers HNB and COMB.
With 9MCY17 earnings at Rs. 8.8bn (+27% YoY), we have upgraded our full year earnings projection to Rs. 11.4bn for CY17 (+20% YoY). SAMP reduced its 3 month and 1 year FD rates twice in October 2017 - with current rates at 8.5% and 10.25% respectively (vs. rates of 10.92% and 12% respectively as at end 3QCY17) - which should translate to improved NIMs amid continued strong loan book growth and an improved cost to income ratio YoY. At its current price of Rs. 344.50, SAMP trades at a CY17E P/E of 5.6x (based on current share count) and a P/BV of 1.1x (based on NAVPS as at end September 2017), at an unwarranted discount to our banking & finance coverage universe P/E and continues to offer a strong value proposition to long term investors.
•JKSB is one of 15 founding members of the Colombo Stock Exchange with roots in share trading dating back to 1896, and is a subsidiary of John Keells Holdings PLC (JKH), the largest listed entity on the Colombo Stock Exchange with a market capitalization of US$ 1.3bn.
•JKSB’s core client base is Foreign Institutional Investors, Local Institutions and HNWI’s
•JKSB has a co-branded Research tie up with CIMB and a Research Referral agreement with Credit Suisse, along with trade execution relationships with several other global and regional securities firms.
•JKSB’s trade execution partners include Credit Suisse, CIMB, Merrill Lynch, Exotix, Daiwa, Convergex, Deutsche Asia Securities and Morgan Stanley
•JKSB is a research contributor to Bloomberg on ‘KEEL’
•The JKSB Research Universe covers 72 stocks across 15 sectors, with most Research efforts focused on approximately 45 of the more liquid counters.
•The JKSB Universe constitutes 67% of total market cap and approximately 80% of turnover at the CSE.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.